Portal de Periódicos da CAPES

Serum enzymes in disease.XIV. Abnormality of levels of transaminases and glycolytic and oxidative enzymes and of liver functions as related to the extent of metastatic carcinoma of the liver

1963; Wiley; Volume: 16; Issue: 11 Linguagem: Inglês

10.1002/1097-0142(196311)16

1097-0142

Cecilio O. Tan, Jacobo Cohen, Michael West, Hyman J. Zimmerman,

Digestive system and related health

CancerVolume 16, Issue 11 p. 1373-1387 ArticleFree Access Serum enzymes in disease. XIV. Abnormality of levels of transaminases and glycolytic and oxidative enzymes and of liver functions as related to the extent of metastatic carcinoma of the liver Cecilio O. Tan M.D., Cecilio O. Tan M.D. Departments of Medicine, Chicago Medical School and Mount Sinai Hospital, 2755 W. 15th St., Chicago 8, Ill. Fellow, U.S. Public Health Service.Search for more papers by this authorJacobo Cohen M.D., Jacobo Cohen M.D. Departments of Medicine, Chicago Medical School and Mount Sinai Hospital, 2755 W. 15th St., Chicago 8, Ill. Goldblatt Fellow for Cancer Research.Search for more papers by this authorMichael West M.D., Michael West M.D. Departments of Medicine, Chicago Medical School and Mount Sinai Hospital, 2755 W. 15th St., Chicago 8, Ill.Search for more papers by this authorHyman J. Zimmerman M.D., Hyman J. Zimmerman M.D. Departments of Medicine, Chicago Medical School and Mount Sinai Hospital, 2755 W. 15th St., Chicago 8, Ill.Search for more papers by this author Cecilio O. Tan M.D., Cecilio O. Tan M.D. Departments of Medicine, Chicago Medical School and Mount Sinai Hospital, 2755 W. 15th St., Chicago 8, Ill. Fellow, U.S. Public Health Service.Search for more papers by this authorJacobo Cohen M.D., Jacobo Cohen M.D. Departments of Medicine, Chicago Medical School and Mount Sinai Hospital, 2755 W. 15th St., Chicago 8, Ill. Goldblatt Fellow for Cancer Research.Search for more papers by this authorMichael West M.D., Michael West M.D. Departments of Medicine, Chicago Medical School and Mount Sinai Hospital, 2755 W. 15th St., Chicago 8, Ill.Search for more papers by this authorHyman J. Zimmerman M.D., Hyman J. Zimmerman M.D. Departments of Medicine, Chicago Medical School and Mount Sinai Hospital, 2755 W. 15th St., Chicago 8, Ill.Search for more papers by this author First published: November 1963 https://doi.org/10.1002/1097-0142(196311)16:11 3.0.CO;2-RCitations: 17 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Ariel, I. M.; and Shahon, D. B.: Hepatic dysfunction in candidates for abdominal surgery, especially in patients with cancer. Cancer 3: 608–623, 1950. 2 Baden, H.; Engberg, H.; Iversen, K.; and Jagt, T.: Value of serum glutamic oxalacetic transaminase in detecting subclinical liver metastases. Arch. Surg. 81: 608–610, 1960. 3 Baker, R.; and Govan, D.: Effect of hormonal therapy of prostatic cancer on serum aldolase. Cancer Res. 13: 141–146, 1953. 4 Bargen, J. A.; and Rankin, F. W.: Tests of hepatic function in carcinoma; their value in cases of neoplasm of colon with and without metastasis to liver. Ann. Surg. 91: 225–232, 1930. 5 Bierman, H. R.; Hill, B. R.; Reinhardt, L.; and Emory, E.: Correlation of serum lactic dehydrogenase activity with clinical status of patients with cancer, lymphomas, and leukemias. Cancer Res. 17: 660–667, 1957. 6 Bodansky, A.: Determination of plasma phosphatase. Proc. Soc. Exper. Biol. & Med. 28: 760–762, 1931. 7 Bodansky, O.: Serum phosphohexose isomerase in cancer; I, method of determination and establishment of range of normal values. Cancer 7: 1191–1199, 1954. 8 Bodansky, O.: Serum phosphohexose isomerase in cancer; II, as index of tumor growth in metastatic carcinoma of breast. Cancer 7: 1200–1226, 1954. 9 Bodansky, O.: Serum phosphohexose isomerase in cancer; III, as index of tumor growth in metastatic carcinoma of prostate. Cancer 8: 1087–1114, 1955. 10 Bodansky, O.: Blood biochemical alterations in neoplastic disease. M. Clin. North America 40: 611–628, 1956. 11 Bodansky, O.: Serum phosphohexose isomerase in cancer; IV, comparison with serum-phosphoglucomutase activity in metastatic cancer. Cancer 10: 865–876, 1957. 12 Bodansky, O.; and Scholler, J.: Comparison of phosphohexose isomerase and lactic dehydrogenase activities in plasma, liver, and tumor tissue of tumorbearing rats. Cancer Res. 16: 894–899, 1956. 13 Bodansky, O.; Schwartz, M. K.; Krugman, S.; Giles, J. P.; and Jacob, A. M.: Comparison of activities of isocitric dehydrogenase and glutamic-oxalacetic transaminase in serum infectious hepatitis. Pediatrics 25: 807–811, 1960. 14 Bullard, R. W., Jr.: Alkaline phosphatase and metastatic liver disease. Surgery 19: 379–382, 1946. 15 Cernock, W. F.: Jaundice due to metastatic obstructive lesions. Ann. Int. Med. 39: 369–371, 1953. 16 Chinsky, M.; and Sherry, S.: Serum transaminase as diagnostic aid. A. M. A. Arch. Int. Med. 99: 556–568, 1957. 17 Cleve, E. A.; Gibson, J. R.; and Webb, W. M.: Atypical tuberculosis of liver with jaundice. Ann. Int. Med. 41: 251–260, 1954. 18 Cohen, N. N.; Potter, H. P., Jr., and Bowers, G. N., Jr.: Evaluation of isocitric dehydrogenase in liver disease. Ann. Int. Med. 55: 604–609, 1961. 19 Fenster, L. F.; and Klatskin, G.: Manifestations of metastatic tumors of liver; study of 81 patients subjected to needle biopsy. Am. J. Med. 31: 238–248, 1961. 20 Fitzsimons, E. J.; Sommers, H. M.; and Laipply, T. C.: Value of simultaneous urine bilirubin and serum alkaline phosphatase analyses in diagnosis of intrahepatic metastases of carcinoma. J. Lab. & Clin. Med. 54: 192–196, 1959. 21 Gelb, D.; West, M.; and Zimmerman, H. J.: Relation of Bodansky to King-Armstrong method for determination of serum alkaline phosphatase. Am. J. Clin. Path. 38: 198–202, 1962. 22 Gibbons, T. B.: Hyperphosphatasemia in patients without jaundice with hepatobiliary disease. J. A. M. A. 164: 22–28, 1957. 23 Greene, C. H.; McVicar, C. S.; Walters, W.; and Rowntree, L. G.: Diseases of liver; IV, functional tests in cases of cancer of liver and biliary tract. Arch. Int. Med. 36: 542–560, 1925. 24 Gutman, A. B.; Olson, K. B.; Gutman, E. B.; and Flood, C. A.: Effect of disease of liver and biliary tract upon phosphatase activity of serum. J. Clin. Invest. 19: 129–152, 1940. 25 Hanger, F. M.: Meaning of liver function tests. Am. J. Med. 16: 565–573, 1954. 26 Henry, L.: Serum transaminase levels in liver disease. J. Clin. Path. 12: 131–137, 1959. 27 Herbut, P. A.; and Watson, J. S.: Metastatic cancer of extrahepatic bile ducts producing jaundice. Am. J. Clin. Path. 16: 365–372, 1946. 28 Hill, B. R.; and Levi, C.: Elevation of serum component in neoplastic disease. Cancer Res. 14: 513–515, 1954. 29 Hill, J. H.: Serum lactic dehydrogenase in cancer patients. J. Nat. Cancer Inst. 18: 307–313, 1957. 30 Horn, H. D.; and Amelung, D.: Serum transaminases and lactic dehydrogenase in patients with liver disease. German M. Monthly 3: 46–55, 1958. 31 Kerppola, W.; Nikkila, E. A.; and Pitkanen, E.: Serum TPN-linked enzymes glucose-6-phosphate dehydrogenase, isocitric dehydrogenase and glutathione reductase activities in health and various disease states. Acta med. scandinav. 164: 357–365, 1959. 32 Kingsley, G. R.: Direct biuret method for determination of serum proteins as applied to photoelectric and visual colorimetry. J. Lab. & Clin. Med. 27: 840–845, 1942. 33 Klatskin, G.; and Yesner, R.: Hepatic manifestation of sarcoidosis and other granulomatous diseases; study based on histological examination of tissue obtained by needle biopsy of liver. Yale J. Biol. & Med. 23: 207–248, 1950. 34 Korn, R. J.; Kellow, W. F.; Heller, P.; Chomet, B.; and Zimmerman, H. J.: Hepatic involvement in extrapulmonary tuberculosis; histologic and functional characteristics. Am. J. Med. 27: 60–71, 1959. 35 Korn, R. J.; West, M.; Davis, D. P.; and Gibbel, M. I.: Serum enzymes; their value in diagnosis and management of surgical diseases. S. Clin. North America 42: 249–266, 1962. 36 Longcope, W. T.; and Freiman, D. G.: Study of sarcoidosis based on combined investigation of 160 cases including 30 autopsies from Johns Hopkins Hospital and Massachusetts General Hospital. Medicine 31: 1–132, 1952. 37 Lowry, O. H.; Roberts, N. R.; Wu, M.-L., Hixon, W. S.; and Crawford, E. J.: Quantitative histochemistry of brain; II, enzyme measurements. J. Biol. Chem. 207: 19–37, 1954. 38 Maclagan, N. F.: Thymol turbidity test; new indicator of liver dysfunction. Nature, London 154: 670–671, 1944. 39 Mainland, D.: Elementary Medical Statistics; the Principles of Quantitative Medicine. Philadelphia, Pa. W. B. Saunders Company. 1952; p. 294. 40 Malloy, H. T.; and Evelyn, K. A.: Determination of bilirubin with photoelectric colorimeter. J. Biol. Chem. 119: 481–490, 1937. 41 Manso, C.; and Wróblewski, F.: Glutathione reductase activity in blood and body fluids. J. Clin. Invest. 37: 214–218, 1958. 42 Mateer, J. G.; Baltz, J. I.; Marion, D. F.; and MacMillan, J. M.: Liver function tests; general evaluation of liver function tests, and appraisal of comparative sensitivity and reliability of newer tests, with particular emphasis on cephalin-cholesterol flocculation test, intravenous hippuric acid test and improved bromsulphalein test with new normal standard. J. A. M. A. 121: 723–728, 1943. 43 Mendelsohn, M. L.; and Bodansky, O.: Value of liver-function tests in diagnosis of intrahepatic metastases in nonicteric cancer patient. Cancer 5: 1–8, 1952. 44 Meranze, D. R.; Meranze, T.; and Rothman, M. M.: Serum alkaline phosphatase as aid in diagnosis of metastasis of cancer to liver. Pennsylvania M. J. 41: 1160–1164, 1937–1938. 45 Molander, D. W.: Comparative value of transaminase, cholinesterase and alkaline phosphatase in primary and metastatic neoplasms of liver. [Abstr]. Gastroenterology 34: 1047, 1958. 46 Neefe, J. R.; and Reinhold, J. G.: Photosensitivity as cause of falsely positive cephalin-cholesterol flocculation tests. Science 100: 83–85, 1944. 47 Neilands, J. B.: Lactic dehydrogenase of heart muscle. In S. P. Colowick; and N. O. Kaplan; Eds.: Methods in Enzymology, vol. 1. New York, N.Y. Academic Press Inc. 1955; pp. 449–454. 48 Ochoa, S.: Malic dehydrogenase from pig heart. In S. P. Colowick; and N. O. Kaplan; Eds.: Methods in Enzymology, vol. 1. New York, N.Y. Academic Press Inc. 1955; pp. 735–739. 49 Ogryzlo, M. A.; Machlachlan, M.; Dauphinee, J. A.; and Fletcher, A. A.: Serum proteins in health and disease; filter paper electrophoresis. Am. J. Med. 27: 596–616, 1959. 50 Okumura, M.; and Spellberg, M. A.: Serum isocitric dehydrogenase activity in differential diagnosis of liver disease. Gastroenterology 39: 305–311, 1960. 51 Ottenberg, R.; Rosenfeld, S.; and Goldsmith, L.: Clinical value of serum tetrachlorphenolphthalein test for liver function. Arch. Int. Med. 34: 206–227, 1924. 52 Paulson, M.; and Wyler, C. I.: Multiple tests of hepatic function in gastroenteric malignancy; value of bromsulphalein, hippuric acid and van den Berg reaction in detecting hepatic metastasis, with evaluation of normality of hippuric acid test. Ann. Int. Med. 16: 872–878, 1942. 53 Pryse-Davies, J.; and Wilkinson, J. H.: Diagnostic value of serum-transaminase activity in hepatic and gastrointestinal diseases. Lancet 1: 1249–1253, 1958. 54 Racker, E.: Glutathione reductase (liver and yeast). In S. P. Colowick; and N. O. Kaplan; Eds.: Methods in Enzymology, vol. 2. New York, N.Y. Academic Press Inc. 1955; pp. 722–725. 55 Reitman, S.; and Frankel, S.: Colorimetric method for determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Path. 28: 56–63, 1957. 56 Rose, A.; West, M.; and Zimmerman, H. J.: Serum enzymes in disease; V, isocitric dehydrogenase, malic dehydrogenase, glycolytic enzymes in patients with carcinoma of breast. Cancer 14: 726–733, 1961. 57 Ross, P. H.; and Weinberg, B. J.: Chronic regurgitation jaundice as presenting sign in sarcoidosis. A. M. A. Arch. Int. Med. 87: 269–273, 1951. 58 Ross, R. S.; Iber, F. L.; and Harvey, A. M.: Serum alkaline phosphatase in chronic infiltrative disease of liver. Am. J. Med. 21: 850–856, 1956. 59 Schwartz, M. A.; Walsh, W. S.; West, M.; and Zimmerman, H. J.: Serum enzymes in disease; X, glycolytic and oxidative enzymes and transaminases in patients with carcinoma of head, neck, and esophagus. Cancer 15: 927–930, 1962. 60 Schwartz, M. A.; West, M.; Walsh, W. S.; and Zimmerman, H. J.: Serum enzymes in disease; VIII, glycolytic and oxidative enzymes and transaminases in patients with gastrointestinal carcinoma. Cancer 15: 346–353, 1962. 61 Schwartz, M. K.; Kessler, B.; and Bodansky, O.: Comparison of serum alkaline phosphatase activities determined with sodium β-glycerophosphate and sodium phenylphosphate as substrates. Am. J. Clin. Path. 33: 275–280, 1960. 62 Shank, R. E.; and Hoagland, C. L.: Modified method for quantitative determination of thymol turbidity reaction of serum. J. Biol. Chem. 162: 133–138, 1946. 63 Sharnoff, J. G.; Lisa, J. R.; and Riedel, P. A.: Serum phosphatase activity in disease of liver; correlation of serum enzyme activity and hepatic histologic changes. Arch. Path. 33: 460–466, 1942. 64 Shay, H.; Berk, J. E.; Sones, M.; Aegerter, E. E.; Weston, J. K.; and Adams, A. B.: Liver in sarcoidosis. Gastroenterology 19: 441–459, 1951. 65 Shay, H.; and Siplet, H.: Value of serum alkaline phosphatase determination and bromsulphalein test in diagnosis of metastatic cancer of liver. J. Lab. & Clin. Med. 43: 741–751, 1954. 66 Sibley, J. [A.], and Fleisher, G. [A.]: Clinical significance of serum aldolase. Proc. Staff Meet. Mayo Clin. 29: 591–603, 1954. 67 Sibley, J. A.; Fleisher, G. A.; and Higgins, G. M.: Significance of level of serum aldolase in tumor-bearing animals. Cancer Res. 15: 306–314, 1955. 68 Sibley, J. A.; and Lehninger, A. L.: Aldolase in serum and tissues of tumor-bearing animals. J. Nat. Cancer Inst. 9: 303–309, 1948–1949. 69 Simons, R. L.: Hepatic tests in metastatic carcinoma of liver; review of 73 cases proven at necropsy. Am. J. M. Sc. 228: 312–316, 1954. 70 Spain, D. M.; and Riley, R. L.: Jaundice in amyloidosis of liver. Am. J. Clin. Path. 14: 284–288, 1944. 71 Sterkel, R. L.; Spencer, J. A.; Wolfson, S. K., Jr., and Williams-Ashman, H. G.: Serum isocitric dehydrogenase activity with particular reference to liver disease. J. Lab. & Clin. Med. 52: 176–184, 1958. 72 Thomas, L. J.; and Zimmerman, H. J.: Pattern of abnormality of liver function in metastatic carcinoma. J. Lab. & Clin. Med. 39: 882–887, 1952. 73 Tonhazy, N. E.; White, N. G.; and Umbreit, W. W.: Rapid method for estimation of glutamicaspartic transaminase in tissues and its application to radiation sickness. Arch. Biochem. 28: 36–42, 1950. 74 Umbreit, W. W.; Kingsley, G. R.; Schaffert, R. R.; and Siplet, H.: Colorimetric method for transaminases in serum or plasma. J. Lab. & Clin. Med. 49: 454–459, 1957. 75 Warburg, O.; and Christian, W.: Gärungsfermente im Blutserum von Tumor-Ratten. Biochem. Ztschr. 314: 399–408, 1943. 76 Watson, C. J.: Regurgitation jaundice; clinical differentiation of common forms, with particular reference to degree of biliary obstruction. J. A. M. A. 114: 2427–2432, 1940. 77 Weichselbaum, T. E.: Accurate and rapid method for determination of proteins in small amounts of blood serum and plasma. Am. J. Clin. Path. (tech. sect. 10) 16: 40–49, 1946. 78 Weinstein, H. G.; Muniak, S.; and Zimmerman, H. J.: Simple sensitive fructoaldolase assay. In Abstracts of Papers, 141st Meeting, American Chemical Society. Washington, D.C. American Chemical Society. 1962; p. 53C. 79 West, M.; Berger, C.; Rony, H.; and Zimmerman, H. J.: Serum enzymes in disease; VI, glutathione reductase in sera of normal subjects and of patients with various diseases. J. Lab. & Clin. Med. 57: 946–954, 1961. 80 West, M.; Gelb, D.; Pilz, C. G.; and Zimmerman, H. J.: Serum enzymes in disease; VII, significance of abnormal enzyme levels in cardiac failure. Am. J. M. Sc. 241: 350–358, 1961. 81 West, M.; Schwartz, M. A.; Walsh, W. S.; and Zimmerman, H. J.: Serum enzymes in disease; XI, glycolytic and oxidative enzymes and transaminase in patients with cancer of lung. Cancer 15: 931–935, 1962. 82 West, M.; Schwartz, M. [A.], and Zimmerman, H. J.: Plasma glycolytic, citric acid cycle, and transaminase enzyme levels in hamsters with transplanted mammary adenocarcinoma. J. Nat. Cancer Inst. 27: 1145–1152, 1961. 83 West, M.; and Zimmerman, H. J.: Serum enzymes in disease; I, lactic dehydrogenase and glutamic oxalacetic transaminase in carcinoma. A. M. A. Arch. Int. Med. 102: 103–114, 1958. 84 White, L. P.: Serum enzymes; II, glycolytic enzymes in patients with cancer and other diseases. J. Nat. Cancer Inst. 21: 671–684, 1958. 85 Wolfson, S. K., Jr., and Williams-Ashman, H. G.: Isocitric and 6-phosphogluconic dehydrogenases in human blood serum. Proc. Soc. Exper. Biol. & Med. 96: 231–234, 1957. 86 Wróblewski, F.: Clinical significance of transaminase activities of serum. Am. J. Med. 27: 911–923, 1959. 87 Wróblewski, F.; Jervis, G.; and LaDue, J. S.: Diagnostic, prognostic and epidemiologic significance of serum glutamic oxaloacetic transaminase (SGO-T) alterations in acute hepatitis. Ann. Int. Med. 45: 782–800, 1956. 88 Wróblewski, F.; and LaDue, J. S.: Serum glutamic-oxalacetic-transaminase activity as index of livercell injury from cancer; preliminary report. Cancer 8: 1155–1163, 1955. 89 Wróblewski, F.; and LaDue, J. S.: Serum glutamic pyruvic transaminase (SGP-T) in hepatic disease; preliminary report. Ann. Int. Med. 45: 801–811, 1956. 90 Zimmerman, H. J.; and Weinstein, H. G.: Lactic dehydrogenase activity in human serum. J. Lab. & Clin. Med. 48: 607–616, 1956. 91 Zimmerman, H. J.; West, M.; and Gelb, D. M.: Clinical significance of hyperglobulinemia. GP 20 (5): 137–144, 1959. Citing Literature Volume16, Issue11November 1963Pages 1373-1387 ReferencesRelatedInformation